"Our hope is that this work will form the basis for designing a neuroprotective drug that could eventually help patients," Pieper says.
“我们的希望是，这项工作将形成设计，最终可能帮助患者的神经保护药物的基础上，”皮珀说。
"We make new neurons every day in our brain," Andrew Pieper of the University of Texas Southwestern Medical Center in Dallas who worked on the study, said in a telephone interview.
“我们每天都生成脑神经元，”位于达拉斯的德克萨斯大学西南医学中心的研究人员安德鲁·派普(AndrewPieper)在电话采访中说。
The compound is similar to Medivation Inc and Pfizer Inc's experimental Alzheimer's drug, Dimebon, and may provide ways to improve its effects, Pieper and colleagues reported in the journal Cell.
根据派普和同事在《细胞》(Cell)期刊上发表的报告，因为与Medivation和辉瑞制药的实验性阿斯海默症治疗药物Dimebon 成份相似，这种化合物有可能提供更多改善该药药效的方法。
The compound is similar to Medivation Inc and Pfizer Inc's experimental Alzheimer's drug, Dimebon, and may provide ways to improve its effects, Pieper and colleagues reported in the journal Cell.
根据派普和同事在《细胞》(Cell)期刊上发表的报告，因为与Medivation和辉瑞制药的实验性阿斯海默症治疗药物Dimebon 成份相似，这种化合物有可能提供更多改善该药药效的方法。
应用推荐